HYBRID PLASTICS — Department of Defense SBIR Phase II: N101-085
HYBRID PLASTICS — SBIR Phase II award from Department of Defense.
Phase II SBIR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $1,000,000 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Topic code N101-085 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.
- Amount
- $1,000,000
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase II
- Topic
- N101-085
- Solicitation
- 10.1
- NAICS
- —
- Place of performance
- MS
- Period
- 2020-09-24 → 2023-01-23
Description
The proposed effort aims to increase the TRL of the hemostatic agent through completion of relevant animal and toxicological research and development. These advancements will be verified through process improvements to meet good manufacturing practices.